MFG Tray Recognizes Distributor
MFG Tray names ChemTech International as its first Master Pharmaceutical Distributor.
Molded Fiber Glass Tray (MFG Tray) has selected ChemTech International as its master pharmaceutical distributor because of ChemTech’s market growth success and the longtime relationship with MFG Tray, according to a MFG Tray press release. The designation, the first offered by MFG Tray, means the ChemTech team is a trusted and valued partner and broadens ChemTech’s opportunities and responsibilities with MFG Tray.
The pharmaceutical line of products manufactured by MFG Tray are used worldwide in the pharmaceutical, nutraceutical, biotech, vaccine, lyophilization, and veterinary science markets. Since 1992, ChemTech has exported and distributed MFG Tray’s pharmaceutical products to destinations including the European Union, South Africa, Southeast Asia, India, South America, and Australia.
Source: Molded Fiber Glass Tray
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
